GLP1R and Parkinson disease: There is growing evidence that GLP-1R activation exerts neuroprotective effects on oxidative stress, neuronal apoptosis, and neuroinflammation in patients with Alzheimer’s disease (AD) or Parkinson’s disease (PD) [34].